| Summary of Calculation of Basic and Diluted Net Loss Per Share |
The following table presents the calculation of basic and diluted net earnings per share attributable to common stockholders (in thousands, except per share amounts): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended
September 30, | | Nine Months Ended
September 30, | | 2024 | | 2023 | | 2024 | | 2023 | | Numerator | | | | | | | | | Net income attributable to common stockholders for diluted net earnings per share | $ | 143,525 | | | $ | 71,505 | | | $ | 383,181 | | | $ | 116,434 | | | Denominator | | | | | | | | Weighted-average shares used in computing net earnings per share: | | | | | | | | | Basic | 2,250,032 | | | 2,162,530 | | | 2,231,790 | | | 2,134,045 | | | Effect of dilutive shares | 209,557 | | | 163,070 | | | 193,074 | | | 147,302 | | | Diluted | 2,459,589 | | | 2,325,600 | | | 2,424,864 | | | 2,281,347 | | | Net earnings per share | | | | | | | | | Net earnings per share attributable to common stockholders: | | | | | | | | | Basic | $ | 0.06 | | | $ | 0.03 | | | $ | 0.17 | | | $ | 0.05 | | | Diluted | $ | 0.06 | | | $ | 0.03 | | | $ | 0.16 | | | $ | 0.05 | |
|
| Summary of Antidilutive Securities |
The following outstanding potentially dilutive common stock equivalents have been excluded from the computation of diluted net earnings per share attributable to common stockholders for the periods presented due to their anti-dilutive effect (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended
September 30, | | Nine Months Ended
September 30, | | 2024 | | 2023 | | 2024 | | 2023 | | Options issued and outstanding | — | | | — | | | — | | | 162,000 | | | RSUs and P-RSUs outstanding | 6,748 | | | 6,941 | | | 6,748 | | | 12,032 | | | Warrants to purchase common stock | — | | | 13,042 | | | — | | | 13,042 | | | Total | 6,748 | | | 19,983 | | | 6,748 | | | 187,074 | |
|